BRCA1 and breast cancer: While Vik et al. reported a significantly inverse association between OPG and BRCA1/2-associated BC risk [76], Kotsopoulos and colleagues did not find evidence for an association between plasma OPG [77] or sRANKL [78] levels and BC risk.